-5%
Viglimet 50/850mg Tablet is an anti-diabetic medication containing Vildagliptin and Metformin as active ingredients. It is used to treat type 2 diabetes mellitus when diet, exercise, and Vildagliptin or Metformin alone are not effective.
Viglimet 50/850mg Tablet is a combination medication that includes Metformin and Vildagliptin, belonging to the group of antidiabetic agents. It is used to treat type 2 diabetes in adult patients whose diabetes cannot be adequately controlled by diet, exercise alone, or other diabetes medications like insulin or sulphonylureas.
Type 2 diabetes is a chronic condition where the body either doesn’t produce enough insulin or the produced insulin does not work effectively. Common symptoms of type 2 diabetes include excessive urination, thirst, hunger, fatigue, and blurred vision.
Metformin in Viglimet 50/850mg Tablet works by reducing glucose production in the liver, decreasing intestinal glucose absorption, and enhancing insulin sensitivity to improve peripheral glucose uptake and utilization. Vildagliptin, on the other hand, stimulates the pancreas to produce more insulin and less glucagon, leading to lower blood glucose levels.
During the treatment with Viglimet 50/850mg Tablet, it is essential to follow a regular exercise and diet plan as advised by the doctor to achieve better results.
Before taking Viglimet 50/850mg Tablet, inform your doctor if you have any liver, kidney, or heart problems. The use of Viglimet 50/850mg Tablet during pregnancy should only be done if advised by the doctor, and it is not recommended for breastfeeding women. This medication is not suitable for children and adolescents under 18 years of age, and caution should be exercised when using it in elderly patients (65 years and above).